Shenzhen Neptunus Bioengineering Co., Ltd.
SHZ: 000078.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Feng Zhang
- Employees
- 9,093
- Headquarters
- Shenzhen, China
- IPO year
- 1998
- Market cap
- CN¥7.2B
- Website
- https://www.neptunus.com
Loading 000078…
Loading profile data…Frequently asked questions about 000078
What does Shenzhen Neptunus Bioengineering Co., Ltd. (000078.SZ) do?
Shenzhen Neptunus Bioengineering Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products primarily in China. It offers drugs in the fields of anti-tumor, cardio-cerebrovascular, marine drugs, and other fields. The company was founded in 1989 and is based in Shenzhen, China.
Where does 000078.SZ trade?
Shenzhen Neptunus Bioengineering Co., Ltd. (000078.SZ) trades on the Shenzhen Stock Exchange.
What sector is 000078.SZ in?
Shenzhen Neptunus Bioengineering Co., Ltd. (000078.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shenzhen Neptunus Bioengineering Co., Ltd.?
Feng Zhang is the chief executive officer of Shenzhen Neptunus Bioengineering Co., Ltd. (000078.SZ).
Where is Shenzhen Neptunus Bioengineering Co., Ltd. headquartered?
Shenzhen Neptunus Bioengineering Co., Ltd. is headquartered in China.
Does 000078.SZ pay a dividend?
Shenzhen Neptunus Bioengineering Co., Ltd. (000078.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 000078.SZ go public?
Shenzhen Neptunus Bioengineering Co., Ltd. (000078.SZ) completed its initial public offering in 1998.